Clinical and Cost-Effectiveness of a Comprehensive Geriatric Assessment in Canada Elders Receiving Chemotherapy
The Primary Objective of the 5C study is to determine the clinical effectiveness of the intervention on maintaining/improving quality of life in older adults aged > 70 years referred for adjuvant/curative or first/second line palliative chemotherapy compared to usual oncology care.
A cost-effectiveness analysis will also be done alongside the clinical trial.
THE STUDY WILL BE CONDUCTED AT THE FOLLOWING:
University Health Network, Toronto
The Ottawa Hospital, Ottawa
Sir Mortimer B. Davis - Jewish General Hospital, Montreal
R.S. McLaughlin Durham Cancer Centre, Lakeridge Health, Oshawa
Sunnybrook Health Sciences Centre, Toronto
Fraser Health- Royal Columbian Hospital, Surrey
Mount Sinai Hospital, Toronto
For more information, please contact the study PI:
Dr. Martine Puts
Funding provided by: Canadian Cancer Society